Astragaloside IV promotes neuronal axon regeneration by inhibiting the PTEN/AKT pathway
Brain Research · 2025
DOI: 10.1016/j.brainres.2025.149451 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Research, 2025. Verfasst von Luning Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine Pharmacy, Wenling Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical Universi…. Hauptthemen laut MEDLINE: Saponins, Triterpenes, Neurons, Axons. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Neuronal survival and regeneration are critical aspects of recovery from ischemic brain injuries. Astragaloside IV (AS-IV), a saponin extracted from the traditional Chinese medicine Astragalus membranaceus, has shown promise in promoting neuronal health. This study investigates the effects of AS-IV on neuronal survival and apoptosis post-oxygen-glucose deprivation (OGD), focusing on the modulation of the PTEN/AKT signaling pathway. METHODS: Rat primary neuronal cells were isolated and subjected to OGD to simulate ischemic conditions. Afterwards, cells were treated with low and high doses of AS-IV. Neuronal viability and apoptosis were assessed using MTT and flow cytometry (FCM) assays. Immunofluorescence and Western blot analyses were performed to evaluate the expression of neuronal markers and proteins involved in the PTEN/AKT pathway. RESULTS: Post-OGD, neuronal cells exhibited decreased viability and increased apoptosis, which were significantly mitigated by AS-IV. Immunofluorescence showed enhanced Tuj1 expression, indicating increased neuronal purity and survival, enhanced NF200 expression, indicating increased axon lengths. FCM results revealed reduced apoptosis rates, particularly with higher doses of AS-IV. Western blot analysis confirmed inhibition of PTEN and activation of AKT, facilitating enhanced neuronal survival and axona regeneration. Additionally, overexpression of PTEN negated the anti-apoptotic effects of AS-IV, underscoring the critical role of the PTEN/AKT pathway in AS-IV mediated neuroprotection. CONCLUSION: AS-IV enhances neuronal survival and axona regeneration by modulating the PTEN/AKT pathway, highlighting its potential as a therapeutic agent for ischemic brain injuries. These findings suggest that targeting this pathway could be a strategic focus for developing effective neuroprotective therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Traditional Chinese Medicine Pharmacy, Wenling Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Taizhou 317500, China.
- Department of Clinical Lab, Taizhou Hospital of Traditional Chinese and Western Medicine, Taizhou 317200, China.
- Department of Acupuncture and Moxibustion, Wenling Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Taizhou 317500, China.
- Department of Pharmacy, Wenling Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Taizhou 317500, China.
- Department of Traditional Chinese Medicine Pharmacy, Wenling Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Taizhou 317500, China. Electronic address: zhengxintian@alu.zcmu.e…
Zitieren
APA
Lin, L., Zhao, C., Lv, H., Zhu, L., Wang, W., & Zheng, X. (2025). Astragaloside IV promotes neuronal axon regeneration by inhibiting the PTEN/AKT pathway. Brain Research. https://doi.org/10.1016/j.brainres.2025.149451
Vancouver
Lin L, Zhao C, Lv H, Zhu L, Wang W, Zheng X. Astragaloside IV promotes neuronal axon regeneration by inhibiting the PTEN/AKT pathway. Brain Research. 2025. doi:10.1016/j.brainres.2025.149451
BibTeX
@article{Lin2025,
author = {Lin, Luning and Zhao, Chenyang and Lv, Huijuan and Zhu, Liangrong and Wang, Wangen and Zheng, Xintian},
title = {Astragaloside IV promotes neuronal axon regeneration by inhibiting the PTEN/AKT pathway},
journal = {Brain Research},
year = {2025},
doi = {10.1016/j.brainres.2025.149451}
}
EUVIMED